APA (7th ed.) Citation

Wang, D., Chang, A., Shea, F., He, Y., Spinney, R., Whitsett, J. D., . . . Mallery, S. R. (2025). Engineered Fenretinide- and Tocilizumab-Releasing Janus Nanoparticles for Site-Directed Immunochemoprevention of Squamous Cell Carcinoma of the Lung. Pharmaceutics, 17(11), 1471. https://doi.org/10.3390/pharmaceutics17111471

Chicago Style (17th ed.) Citation

Wang, Daren, Albert Chang, Fortune Shea, Yifei He, Richard Spinney, Jonathan D. Whitsett, Joerg Lahann, and Susan R. Mallery. "Engineered Fenretinide- and Tocilizumab-Releasing Janus Nanoparticles for Site-Directed Immunochemoprevention of Squamous Cell Carcinoma of the Lung." Pharmaceutics 17, no. 11 (2025): 1471. https://doi.org/10.3390/pharmaceutics17111471.

MLA (9th ed.) Citation

Wang, Daren, et al. "Engineered Fenretinide- and Tocilizumab-Releasing Janus Nanoparticles for Site-Directed Immunochemoprevention of Squamous Cell Carcinoma of the Lung." Pharmaceutics, vol. 17, no. 11, 2025, p. 1471, https://doi.org/10.3390/pharmaceutics17111471.